Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy

PloS One
Martin Lubin, Adam Lubin

Abstract

The gene for methylthioadenosine phosphorylase (MTAP) lies on 9p21, close to the gene CDKN2A that encodes the tumor suppressor proteins p16 and p14ARF. MTAP and CDKN2A are homozygously co-deleted, with a frequency of 35 to 70%, in lung and pancreatic cancer, glioblastoma, osteosarcoma, soft-tissue sarcoma, mesothelioma, and T-cell acute lymphoblastic leukemia. In normal cells, but not in tumor cells lacking MTAP, MTAP cleaves the natural substrate, 5'-deoxy-5'-methylthioadenosine (MTA), to adenine and 5-methylthioribose-1-phosphate (MTR-1-P), which are then converted to adenine nucleotides and methionine. This distinct difference between normal MTAP-positive cells and tumor MTAP-negative cells led to several proposals for therapy. We offer a novel strategy in which both MTA and a toxic adenine analog, such as 2,6-diaminopurine (DAP), 6-methylpurine (MeP), or 2-fluoroadenine (F-Ade), are administered. In MTAP-positive cells, abundant adenine, generated from supplied MTA, competitively blocks the conversion of an analog, by adenine phosphoribosyltransferase (APRT), to its active nucleotide form. In MTAP-negative tumor cells, the supplied MTA cannot generate adenine; hence conversion of the analog is not blocked. We show that this...Continue Reading

References

Jul 14, 1978·Biochemical and Biophysical Research Communications·J I Toohey
Nov 1, 1974·Journal of Medicinal Chemistry·J A MontgomeryH J Thomas
Nov 1, 1969·The Biochemical Journal·Anthony E Pegg, H G Williams-Ashman
Oct 1, 1983·Biochemical Pharmacology·M J Tisdale
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·N KamataniD A Carson
Feb 1, 1982·Biochemical Pharmacology·H G Williams-AshmanP Galletti
Jan 15, 1983·Biochemical Pharmacology·R HeimerE Cadman
Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph R Bertino
Jul 5, 1996·The Journal of Biological Chemistry·F D RagioneV Zappia
Feb 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·Vijayakrishna K GadiEric J Sorscher
Jul 24, 2003·The American Journal of Pathology·Iris BehrmannAnja-Katrin Bosserhoff
Nov 25, 2005·Current Topics in Medicinal Chemistry·Yang ZhangS E Ealick
Dec 24, 2005·Molecular Cancer Therapeutics·Collins A KarikariAnirban Maitra
Jan 24, 2006·Journal of Biochemistry·Yoshihiko IkeguchiAnthony E Pegg
Jun 6, 2007·The Journal of Biological Chemistry·Indranil BasuVern L Schramm
Oct 24, 2007·Antimicrobial Agents and Chemotherapy·J R SufrinC J Bacchi
Mar 28, 2008·The Journal of Biological Chemistry·Hong WuAlexander N Plotnikov
Jun 17, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fumiaki WatanabeHideto Shimpo
Apr 1, 1993·Journal of General Internal Medicine·P J Cozzi

Citations

Jan 16, 2014·Annual Review of Medicine·Ekaterina Bobrovnikova-Marjon, Jonathan B Hurov
Jan 19, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alyssa M KrasinskasSanja Dacic
Jun 17, 2010·Nature Reviews. Clinical Oncology·Charles FertéJean-Charles Soria
May 8, 2010·Chromosoma·Olga TapiaMiguel Lafarga
Jun 2, 2010·Cancer Genetics and Cytogenetics·Sarah Franco Vieira de OliveiraEnilze Maria de Souza Fonseca Ribeiro
Nov 23, 2011·Statistics in Medicine·Shuangge MaKuangnan Fang
Feb 9, 2011·Cancer Biology & Therapy·Joseph R BertinoMartin Lubin
Mar 4, 2017·Metabolomics : Official Journal of the Metabolomic Society·Emilia Daghir-WojtkowiakMichał Jan Markuszewski
Dec 16, 2017·Biomarkers in Medicine·Lucas Faria Abrahao-MachadoOlavo Pires de Camargo
Jan 21, 2017·F1000Research·Carl YoussefCarlos A Bagley
Jun 15, 2014·The Oncologist·Pashna N MunshiJoseph R Bertino
Jan 12, 2016·PloS One·Sarah Franco Vieira de OliveiraEnilze Maria de Souza Fonseca Ribeiro
Sep 14, 2019·Nature Reviews. Cancer·Sydney M SandersonJason W Locasale
Jun 30, 2019·Science Advances·Sydney M SandersonJason W Locasale
Dec 25, 2019·Cold Spring Harbor Molecular Case Studies·Elisa MajounieJanessa Laskin
Mar 9, 2011·Journal of Neuro-oncology·Roberto Jose Diaz, Michael D Cusimano
Feb 2, 2011·Molecular Cancer Therapeutics·Sally A CoulthardLinda A Hogarth
Sep 19, 2019·Cell Reports·Changzheng DuYiping He
Feb 23, 2021·Frontiers in Pharmacology·Patricia GiulianiRenata Ciccarelli

Related Concepts

5'-Methylthioadenosine phosphorylase
5'-deoxyadenosine
Adenine
Deoxyadenosines
Dye Exclusion Assays, Antitumor
5-FU medac
Malignant Neoplasms
Nicotinamide Riboside Phosphorylase
Tioguanina Wellcome
Cell Death

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
José M García-CastellanoRichard Gorlick
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Peter B IlleiMarc Ladanyi
Gynecologic and Obstetric Investigation
Y F WongA M Chang
© 2021 Meta ULC. All rights reserved